Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study

Cornelia Then1,2, Chaterina Sujana2,3,4, Christian Herder5,6,7

  • 1Department of Internal Medicine IV, University Hospital of Ludwigs-Maximilians-University Munich, Munich, Germany.

Insights

C-terminal pro-endothelin-1 (CT-proET-1) is a risk marker for all-cause mortality, independent of cardiovascular disease and inflammation. This study found CT-proET-1 associated with increased mortality but not cardiovascular events or atherosclerosis markers.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disease Research
  • Biomarker Discovery

Background:

  • Endothelin-1 and its precursor CT-proET-1 are implicated in metabolic disorders, inflammation, and cardiovascular events.
  • Previous studies suggest a link between CT-proET-1 and adverse health outcomes in specific populations.

Purpose of the Study:

  • To investigate the association of CT-proET-1 with cardiovascular events, mortality, carotid intima-media thickness, subclinical inflammation biomarkers, and adipokines.
  • To analyze these associations within a general population-based study.

Main Methods:

  • Utilized data from the KORA F4 study with a median follow-up of 9.1 years.
  • Employed multivariable regression and Cox proportional hazard models, adjusting for numerous cardiovascular risk factors.
  • Corrected for multiple testing using the Bonferroni method.

Main Results:

  • CT-proET-1 was significantly associated with increased cardiovascular and all-cause mortality (HRs 1.66 and 2.03, respectively).
  • No association was found with cardiovascular events, but an inverse association with carotid intima-media thickness was observed.
  • CT-proET-1 correlated positively with several subclinical inflammation biomarkers and some adipokines.

Conclusions:

  • CT-proET-1 serves as a risk marker for all-cause mortality, potentially independent of vascular endothelin-1 actions, cardiovascular disease, and inflammation.
  • The findings highlight the complex role of endothelin-1 pathways and the indicator function of CT-proET-1.
Abstract

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
234
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
108
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
529
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
64